Filter Search


Healthcare and Medical


Location Summary Deadline
Germany Medicines With The Active Ingredient Rotigotine (atc 2025-11-18
France Supply Of Pharmaceutical Specialties In The Context Of Competition And New Needs For The Benefit Of Members Of The Gcs Graps Grand Is A Dynamic Acquisition System 2025-11-18
Germany Open House Medicinal Properties Naltrexon, Atc N07bb04 2025-11-18
Germany Open House Medicinal Department Axitinib, Atc L01ek01 2025-11-18
Germany Open House Original Discount Contracts 202520 Metformin/dapagliflozin (combination Of Active Ingredients) 2025-11-18
Germany Completion Of A Non -excessive Discount Agreement According To § 130a Paragraph 8 Sgb V On The Active Ingredient Vedolizumab, Atc L04aa33 For The Period 01.07.2025 30.2027 2025-11-18
Germany Completion Of A Non -excessive Discount Agreement According To § 130a Para. 8 Sgb V For The Active Ingredient Dolutegravir + Rilpivirin, Atc J05ar21 For The Time 01.07.2025 30.2027 2025-11-18
Germany Completion Of A Non -excessive Discount Agreement According To § 130a Para. 8 Sgb V For The Active Ingredient Lamivudin + Abacavir + Dolutegravir, Atc J05ar13 For The Time 01.07.2025 30.2027 2025-11-18
Germany Completion Of A Non -excessive Discount Agreement According To § 130a Para. 8 Sgb V For The Active Ingredient Denosumab, Atc M05bx04 For The Time 01.07.2025 30.06.2026 (plus Extension Option 1x 12 Months) 2025-11-18
Germany Openhouser Discount Contracts 202406 2025-11-18
Whats app